American College of Rheumatology Annual Meeting

Healio brings you the highlights from the American College of Rheumatology Annual Meeting. Refer back to this page often for the latest news from ACR, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Secukinumab does not increase IBD incidence in patients with psoriasis, spondyloarthropathies

February 22, 2017
Reports of Crohn’s disease and ulcerative colitis among patients with psoriasis, psoriatic arthritis or ankylosing spondylitis treated with…
Meeting News

TNF inhibitors may impact hip disease among patients with ankylosing spondylitis

February 21, 2017
Treatment with tumor necrosis factor inhibitors was associated with decreased radiographic hip progression among patients with ankylosing…
Meeting News

Age does not affect disease activity, management in ankylosing spondylitis

February 16, 2017
Markers of disease activity and treatment trends appear to be similar among geriatric patients with ankylosing spondylitis compared with younger

Patients identify weight gain as most important glucocorticoid side effect

January 30, 2017
WASHINGTON — Patients identified weight gain as the most important glucocorticoid side effect, according to the results a survey analysis…
Meeting News

Sex-specific associations found for improvement during rehabilitation for total hip arthroplasty

January 27, 2017
WASHINGTON — Researchers from the University of Illinois found sex-specific associations for improvements in self-reported pain and function…
Meeting News

Light physical activity reduced risk of limitation from osteoarthritis

January 26, 2017
WASHINGTON — Replacement of sedentary time with light physical activity reduced the risk of functional limitation in patients with knee…
Meeting News

Apremilast provides sustained improvement in patients with psoriatic arthritis

January 26, 2017
Apremilast demonstrated continued improvements in several disease markers of psoriatic arthritis, with onset of efficacy occurring by Week 2…
Meeting News

Tofacitinib showed safety in 3-year, real-world analysis for RA

January 26, 2017
WASHINGTON — Tofacitinib showed safety comparable to other disease modifying anti-rheumatic drugs for the treatment of rheumatoid arthritis…
Meeting News

Long-term extension studies on tofacitinib: Discontinuation most commonly associated with adverse events

January 25, 2017
WASHINGTON — Discontinuation of tofacitinib was most commonly associated with adverse events, such as infections, according to long-term…
Meeting News

Study: Subcutaneous adalimumab, etanercept most likely to be used as first-line biologic for RA

January 25, 2017
WASHINGTON — Researchers assessed biologic utilization patterns among patients with rheumatoid arthritis treated with subcutaneous…

Meeting Calendar

American College of Rheumatology Annual Meeting

November 11, 2016 - November 16, 2016

  • Location: Washington D.C.
  • Website
Advertisement
Advertisement